Figure 1From: Multidimensional protein fractionation using ProteomeLab PF 2D™ for profiling amyotrophic lateral sclerosis immunity: A preliminary report Experimental design. Experimental design of multidimensional fractionation using plasma from ALS patients involved in a phase II clinical trial with GA.Back to article page